STOCK TITAN

[Form 4] PetMed Express, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Douglas Krulik, Chief Accounting Officer of PetMed Express, Inc. (PETS), reported a non‑derivative equity grant on 09/09/2025. The filing shows a restricted stock award of 10,000 shares granted at a $0 purchase price under the companys 2024 Omnibus Incentive Plan. After the grant Mr. Krulik beneficially owns 50,000 shares. The award is scheduled to vest in full on the six‑month anniversary of the grant date provided he remains employed or in service, and the award also vests in full if the company terminates his service prior to full vesting unless the termination is for Cause. The Form 4 is signed by Mr. Krulik on 09/11/2025.

Douglas Krulik, Responsabile della Contabilità di PetMed Express, Inc. (PETS), ha segnalato il 09/09/2025 un premio azionario non derivato. Il verbale indica un award in azioni vincolate di 10.000 azioni assegnate a un prezzo di acquisto pari a 0 USD nell’ambito del piano Omnibus Incentive 2024 dell’azienda. Dopo l’assegnazione, il signor Krulik detiene beneficiariamente 50.000 azioni. L’assegnazione è prevista per vestire integralmente al sesto mese dalla data di assegnazione, a condizione che rimanga impiegato o in servizio, e l’assegnazione si vestirà completamente anche se l’azienda termina il suo servizio prima della vesting completa, a meno che la terminazione non sia per giusta causa. Il Form 4 è stato firmato dal signor Krulik l’11/09/2025.
Douglas Krulik, Director de Contabilidad de PetMed Express, Inc. (PETS), informó el 09/09/2025 sobre una adjudicación de acciones no derivadas. El registro muestra una adjudicación de acciones restringidas de 10.000 acciones otorgadas a un precio de compra de 0 USD bajo el Plan Omnibus Incentive 2024 de la empresa. Después de la adjudicación, el Sr. Krulik posee beneficiosamente 50.000 acciones. La adjudicación está programada para consolidarse por completo al cumplir los seis meses desde la fecha de la adjudicación, siempre que permanezca empleado o en servicio, y también se consolida por completo si la empresa termina su servicio antes de la consolidación total, salvo que la terminación sea por causa. El Formulario 4 es firmado por el Sr. Krulik el 11/09/2025.
더글라스 크루릭(Douglas Krulik), PetMed Express, Inc. (PETS)의 최고 회계 책임자는 2025년 9월 9일 비파생 주식 보상을 보고했습니다. 공시에는 2024년 Omnibus Incentive Plan에 따라 0달러의 매입가로 부여된 10,000주 제한 주식 보상이 기재되어 있습니다. 부여 후 크루릭은 유익하게 50,000주를 보유합니다. 이 보상은 부여일로부터 6개월째에 전액 가속 vesting될 예정이며, 그가 고용되어 있거나 서비스를 제공하는 동안 유지되면 가속되고, 또한 회사가 크루릭의 서비스를 완전 vesting 전에 종료하더라도 전액 vesting이 이루어집니다(정당한 사유로 종료되지 않는 한). Form 4는 2025년 9월 11일에 크루릭이 서명했습니다.
Douglas Krulik, directeur comptable de PetMed Express, Inc. (PETS), a déclaré le 09/09/2025 une attribution d’actions non dérivées. Le dossier indique une attribution d’actions restreintes de 10 000 actions accordées à un prix d’achat de 0 USD dans le cadre du Plan Omnibus d’Incitation 2024 de l’entreprise. Après l’attribution, M. Krulik détient bénéficialement 50 000 actions. L’attribution est programmée pour se consolider en entier au sixième mois suivant la date d’attribution, à condition qu’il reste employé ou en service, et l’attribution se consolide également en entier si l’entreprise met fin à son service avant la consolidation complète, sauf si la résiliation est pour cause. Le Formulaire 4 est signé par M. Krulik le 11/09/2025.
Douglas Krulik, Chief Accounting Officer von PetMed Express, Inc. (PETS), meldete am 09/09/2025 eine nicht abgeleitete Eigenkapitalzuteilung. Die Einreichung zeigt eine eingeschränkte Aktienzuweisung von 10.000 Aktien, die zu einem Ausübungspreis von 0 USD unter dem Omnibus Incentive Plan 2024 des Unternehmens gewährt wurde. Nach der Zuteilung besitzt Herr Krulik beneficial 50.000 Aktien. Die Zuweisung soll am sechsten Monat nach dem Zuteilungsdatum vollständig vesten, sofern er beschäftigt oder im Dienst bleibt, und die Zuweisung vestet ebenfalls vollständig, wenn das Unternehmen seinen Dienst vor der vollständigen Vesting beendet, es sei denn, die Beendigung ist aus wichtigem Grund. Das Formular 4 wurde von Herrn Krulik am 11/09/2025 unterschrieben.
دوغلاس كروليك، رئيس المحاسبة في PetMed Express, Inc. (PETS)، أبلغ عن منحة أسهم غير مشتقة في 09/09/2025. يظهر الملف أن منحة أسهم مقيدة قدرها 10,000 سهم مُمنوحة بسعر شراء 0 دولار وفقًا لخطة Omnibus Incentive Plan 2024 للشركة. بعد المنحة، يمتلك السيد كروليك بشكل فعّال 50,000 سهم. منحة الأسهم مٌزمع أن تصبح كاملة التملك عند إتمام ستة أشهر من تاريخ المنحة بشرط بقائه موظفًا أو في الخدمة، كما تكتمل الملكية أيضًا إذا أنهت الشركة خدماته قبل الإكمال الكامل للتملك ما لم يكن إنهاؤه بسبب سبب معقول. يتم توقيع Form 4 من قِبل السيد كروليك في 11/09/2025.
道格拉斯·克鲁里克(Douglas Krulik),PetMed Express, Inc.(PETS)的首席会计官,于2025年9月9日报告了一项非衍生股权授予。申报显示在公司2024年Omnibus Incentive Plan下,按0美元购买价授予的10,000股受限股。授予后,克鲁里克实际持有50,000股。该奖励预计自授予日期起六个月时全部归属,前提是其仍然受雇或在任;如果公司在完全归属前终止其服务,除非因原因而终止,该奖项也将全部归属。Form 4由克鲁里克于2025年9月11日签署。
Positive
  • 10,000 restricted shares granted to the Chief Accounting Officer under the 2024 Omnibus Incentive Plan
  • Award vests in full after six months if the reporting person remains employed or in service, providing short‑term alignment
Negative
  • Award vests upon company termination (unless termination is for Cause), which accelerates insider vesting and may be seen as shareholder‑unfriendly
  • Grant issued at $0 implies dilution without cash inflow to the company

Insights

TL;DR: Routine insider restricted stock grant; limited near‑term dilution and aligns an officer to company performance.

The Form 4 documents a common compensation event: a 10,000‑share restricted stock award to the Chief Accounting Officer at no cash cost to the officer. Vesting in six months creates a short performance/service horizon and modest immediate dilution relative to total outstanding shares (not stated in the filing). The grant price of $0 indicates a standard service‑based award rather than a purchase. This is a routine corporate governance and compensation action that does not, in isolation, change the companys capital structure materially based on the information provided.

TL;DR: Grant terms include standard service vesting but feature an acceleration clause on company termination, which favors the insider.

The restricted award vests on a six‑month anniversary if Mr. Krulik remains in service, and it also vests in full if the company terminates his service prior to full vesting except for terminations for Cause. That acceleration provision benefits the reporting person by protecting vesting on employer‑initiated departures and is notable for governance review. The filing is otherwise procedural and lacks additional governance details such as performance conditions or overall dilution caps.

Douglas Krulik, Responsabile della Contabilità di PetMed Express, Inc. (PETS), ha segnalato il 09/09/2025 un premio azionario non derivato. Il verbale indica un award in azioni vincolate di 10.000 azioni assegnate a un prezzo di acquisto pari a 0 USD nell’ambito del piano Omnibus Incentive 2024 dell’azienda. Dopo l’assegnazione, il signor Krulik detiene beneficiariamente 50.000 azioni. L’assegnazione è prevista per vestire integralmente al sesto mese dalla data di assegnazione, a condizione che rimanga impiegato o in servizio, e l’assegnazione si vestirà completamente anche se l’azienda termina il suo servizio prima della vesting completa, a meno che la terminazione non sia per giusta causa. Il Form 4 è stato firmato dal signor Krulik l’11/09/2025.
Douglas Krulik, Director de Contabilidad de PetMed Express, Inc. (PETS), informó el 09/09/2025 sobre una adjudicación de acciones no derivadas. El registro muestra una adjudicación de acciones restringidas de 10.000 acciones otorgadas a un precio de compra de 0 USD bajo el Plan Omnibus Incentive 2024 de la empresa. Después de la adjudicación, el Sr. Krulik posee beneficiosamente 50.000 acciones. La adjudicación está programada para consolidarse por completo al cumplir los seis meses desde la fecha de la adjudicación, siempre que permanezca empleado o en servicio, y también se consolida por completo si la empresa termina su servicio antes de la consolidación total, salvo que la terminación sea por causa. El Formulario 4 es firmado por el Sr. Krulik el 11/09/2025.
더글라스 크루릭(Douglas Krulik), PetMed Express, Inc. (PETS)의 최고 회계 책임자는 2025년 9월 9일 비파생 주식 보상을 보고했습니다. 공시에는 2024년 Omnibus Incentive Plan에 따라 0달러의 매입가로 부여된 10,000주 제한 주식 보상이 기재되어 있습니다. 부여 후 크루릭은 유익하게 50,000주를 보유합니다. 이 보상은 부여일로부터 6개월째에 전액 가속 vesting될 예정이며, 그가 고용되어 있거나 서비스를 제공하는 동안 유지되면 가속되고, 또한 회사가 크루릭의 서비스를 완전 vesting 전에 종료하더라도 전액 vesting이 이루어집니다(정당한 사유로 종료되지 않는 한). Form 4는 2025년 9월 11일에 크루릭이 서명했습니다.
Douglas Krulik, directeur comptable de PetMed Express, Inc. (PETS), a déclaré le 09/09/2025 une attribution d’actions non dérivées. Le dossier indique une attribution d’actions restreintes de 10 000 actions accordées à un prix d’achat de 0 USD dans le cadre du Plan Omnibus d’Incitation 2024 de l’entreprise. Après l’attribution, M. Krulik détient bénéficialement 50 000 actions. L’attribution est programmée pour se consolider en entier au sixième mois suivant la date d’attribution, à condition qu’il reste employé ou en service, et l’attribution se consolide également en entier si l’entreprise met fin à son service avant la consolidation complète, sauf si la résiliation est pour cause. Le Formulaire 4 est signé par M. Krulik le 11/09/2025.
Douglas Krulik, Chief Accounting Officer von PetMed Express, Inc. (PETS), meldete am 09/09/2025 eine nicht abgeleitete Eigenkapitalzuteilung. Die Einreichung zeigt eine eingeschränkte Aktienzuweisung von 10.000 Aktien, die zu einem Ausübungspreis von 0 USD unter dem Omnibus Incentive Plan 2024 des Unternehmens gewährt wurde. Nach der Zuteilung besitzt Herr Krulik beneficial 50.000 Aktien. Die Zuweisung soll am sechsten Monat nach dem Zuteilungsdatum vollständig vesten, sofern er beschäftigt oder im Dienst bleibt, und die Zuweisung vestet ebenfalls vollständig, wenn das Unternehmen seinen Dienst vor der vollständigen Vesting beendet, es sei denn, die Beendigung ist aus wichtigem Grund. Das Formular 4 wurde von Herrn Krulik am 11/09/2025 unterschrieben.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KRULIK DOUGLAS

(Last) (First) (Middle)
C/O PETMED EXPRESS, INC.
420 SOUTH CONGRESS AVENUE

(Street)
DELRAY BEACH FL 33445

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PETMED EXPRESS INC [ PETS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/09/2025 A 10,000 A(1) $0 50,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted stock award granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan (the "2024 Omnibus Plan"). The award will vest in its entirety on the 6-month anniversary of the grant date so long as Mr. Krulik remains on such date employed by the Company or otherwise in the service of the Company (as a director, consultant, or otherwise) and the award will vest in full in the event that the Company terminates the service by Mr. Krulik with the Company prior to the full vesting of the award unless such termination is for Cause (within the meaning 2024 Omnibus Plan).
Remarks:
/s/ Douglas Krulik 09/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PETS insider Douglas Krulik report on the Form 4?

He reported a restricted stock award of 10,000 shares granted on 09/09/2025 under the 2024 Omnibus Incentive Plan and now beneficially owns 50,000 shares.

When do the restricted shares granted to Mr. Krulik vest?

The award vests in full on the six‑month anniversary of the grant date provided he remains employed or in service; it also vests if the company terminates his service before full vesting unless termination is for Cause.

What was the purchase price for the restricted stock award filed on Form 4?

The transaction price is reported as $0, indicating a grant rather than a purchase.

How many PETS shares does Douglas Krulik beneficially own after the transaction?

He beneficially owns 50,000 shares following the reported transaction.

What is the significance of the acceleration provision in the award?

The award vests if the company terminates his service (unless for Cause), which accelerates vesting and ensures the officer receives the award in many termination scenarios.

On what dates were the transaction and signature made on the Form 4?

Transaction date: 09/09/2025; Signature date: 09/11/2025.
Petmed Express Inc

NASDAQ:PETS

PETS Rankings

PETS Latest News

PETS Latest SEC Filings

PETS Stock Data

57.84M
14.17M
30.82%
37.94%
9.44%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
Link
United States
DELRAY BEACH